Trials / Completed
CompletedNCT03769649
Clinical Evaluation of CelluTite Treatment
Clinical Evaluation of Safety and Efficacy of the CelluTite Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- InMode MD Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This prospective study is intended to evaluate the CelluTite RFAL handpiece combined with Morpheus8 handpiece for the treatment of cellulite.
Detailed description
The study will evaluate the safety and efficacy of cellulite treatment using two hand pieces: * The CelluTite - based on a minimally invasive, temperature-controlled Radiofrequency-assisted lipolysis (RFAL) technology. RF energy is applied using a handpiece with 2 electrodes: internal active electrode with spatula-shaped tip and external electrode. * The Morpheus8 - designed to deliver RF energy to the skin surface in a fractional manner via an array of 24-electrode pins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CelluTite | CelluTite: Radiofrequency-assisted lipolysis (RFAL) Morpheus8: Fractional RF |
Timeline
- Start date
- 2018-11-12
- Primary completion
- 2020-01-17
- Completion
- 2020-01-17
- First posted
- 2018-12-07
- Last updated
- 2022-06-08
- Results posted
- 2021-02-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03769649. Inclusion in this directory is not an endorsement.